Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Apple Turns 50: From Garage Startup to AI Crossroads 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Oregon on behalf of investors who purchased GNC Holdings Inc. (NYSE:GNC) securities between May 2, 2013 and October 22, 2015.
Click here to learn about the case: http://docs.wongesq.com/GNC-Info-Request-Form-1010. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period, Defendants issued materially false and/or misleading information and/or failed to disclose that: (1) GNC unlawfully sold thousands of units of products in Oregon that contained picamilon; (2) GNC unlawfully sold thousands of units of products in Oregon that contained BMPEA; and (3) as a result of the foregoing, the Company’s public statements were materially false and misleading.
On October 22, 2015, the Oregon Department of Justice filed a lawsuit against GNC Holdings claiming that the company’s nutritional and dietary supplements contain picamilon and BMPEA. Said Attorney General Rosenblum, “It is scary to know that certain products sold by GNC contain an ingredient that is not even labeled—let alone approved in the United States.”
If you suffered a loss in GNC Holdings you have until December 28, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/GNC-Info-Request-Form-1010.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
